This company listing is no longer active
BLIRT Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Información clave
75.1%
Tasa de crecimiento de los beneficios
76.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Biotechs | 56.3% |
| Tasa de crecimiento de los ingresos | 55.5% |
| Rentabilidad financiera | 28.5% |
| Margen neto | 19.0% |
| Próxima actualización de resultados | 11 Aug 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Market Cool On BLIRT S.A.'s (WSE:BLR) Earnings Pushing Shares 26% Lower
Oct 02
BLIRT S.A. (WSE:BLR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 02BLIRT's (WSE:BLR) Earnings Are Of Questionable Quality
May 19Will Weakness in BLIRT S.A.'s (WSE:BLR) Stock Prove Temporary Given Strong Fundamentals?
Jan 14
With EPS Growth And More, BLIRT (WSE:BLR) Is Interesting
Dec 09Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero BLIRT. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 21 | 40 | 8 | 19 | 0 |
| 30 Sep 21 | 59 | 19 | 24 | 0 |
| 30 Jun 21 | 67 | 23 | 27 | 0 |
| 31 Mar 21 | 70 | 26 | 25 | 0 |
| 31 Dec 20 | 65 | 22 | 22 | 0 |
| 30 Sep 20 | 36 | 9 | 13 | 0 |
| 30 Jun 20 | 23 | 6 | 9 | 0 |
| 31 Mar 20 | 14 | 0 | 7 | 0 |
| 31 Dec 19 | 10 | -1 | 7 | 0 |
| 30 Sep 19 | 11 | 1 | 7 | 0 |
| 30 Jun 19 | 10 | 1 | 6 | 0 |
| 31 Mar 19 | 9 | -1 | 6 | 0 |
| 31 Dec 18 | 8 | -2 | 6 | 0 |
| 30 Sep 18 | 6 | -3 | 6 | 0 |
| 30 Jun 18 | 6 | -4 | 7 | 0 |
| 31 Mar 18 | 6 | -4 | 7 | 0 |
| 31 Dec 17 | 6 | -3 | 7 | 0 |
| 30 Sep 17 | 5 | -4 | 7 | 0 |
| 30 Jun 17 | 5 | -3 | 6 | 0 |
| 31 Mar 17 | 5 | -4 | 7 | 0 |
| 31 Dec 16 | 5 | -4 | 6 | 0 |
| 30 Sep 16 | 7 | -2 | 7 | 0 |
| 30 Jun 16 | 7 | -2 | 7 | 0 |
| 31 Mar 16 | 7 | -2 | 7 | 0 |
| 31 Dec 15 | 6 | -2 | 7 | 0 |
| 30 Sep 15 | 4 | -3 | 7 | 0 |
Ingresos de calidad: BLR has a high level of non-cash earnings.
Margen de beneficios creciente: BLR's current net profit margins (19%) are lower than last year (34.3%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: BLR has become profitable over the past 5 years, growing earnings by 75.1% per year.
Acelerando crecimiento: BLR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: BLR had negative earnings growth (-66%) over the past year, making it difficult to compare to the Biotechs industry average (5.1%).
Rentabilidad financiera
Alta ROE: BLR's Return on Equity (28.5%) is considered high.